Close mobile menu×
Close mobile menu

Lawrence R. Lustig, MD

Board Certifications: 
Otolaryngology, Neurotology
Accepting New Patients
Treats Children
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 326-8475

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor

Board Certifications

  • Otolaryngology
  • Neurotology

Clinical Expertise

  • Laser Surgery
  • Implantation of Hearing Device In Temporal Bone
  • Implantation of Electromagnetic Hearing Aid
  • Hearing Loss Surgery
  • Facial Nerve Surgery
  • Facial Nerve Disorder
  • EarNose & Throat Surgery
  • EarNose & Throat Problems
  • Earlobe Repair
  • Stapedectomy
  • Ear-Hearing and Balance
  • Skull Base Surgery
  • Ear, Nose, and Throat, Pediatric
  • Pediatric Tumors
  • Ear, Nose, and Throat Problems
  • Pediatric Head and Neck Tumors
  • Ear Tumors
  • Pediatric Head & Neck Surgery
  • Ear Reconstruction
  • Pediatric ENT(earnose and throat)
  • Ear Problems
  • Pediatric Ear Reconstruction
  • Ear Laser Surgery
  • Pediatric Ear Nose Throat Disorder
  • Ear Irrigation
  • Pediatric Ear Infection
  • Ear Infection
  • Pediatric Ear Disease
  • Ear Drum Repair
  • Otorhinolaryngology
  • Ear Drum Perforation
  • Otoplasty/Ear Pinning Surgery
  • Ear Disorder
  • Otoplasty For Prominent Ear Correction
  • Ear Disease
  • Otoplasty
  • Dizzy
  • Otology-Neurotology
  • Dizziness
  • Otology
  • Cosmetic Ear Surgery
  • Otolaryngology Surgery
  • Chronic Ear Infection
  • Otolaryngology
  • Chordoma Tumor
  • Otitis Media
  • Cancer Surgery
  • Neuro Otology
  • Brain Tumor
  • Middle Ear Disease
  • Bell's Palsy
  • Microtia/Ear Deformity Surgery
  • Mastoid Surgery
  • Cholesteatoma
  • Cochlear Implantation
  • Acoustic Neuroma
  • Cancer
  • Skull Base Tumors
  • Otosclerosis
  • Hearing Loss
  • Ear Surgery
  • Tinnitus
  • Facial Nerve Disorders

Education & Training

  • MD, University of California San Francisco School of Medicine
  • Internship: University of California San Francisco Medical Center
  • Residency: University of California San Francisco Medical Center
  • Fellowship: Johns Hopkins Hospital

Honors & Awards

  • 2012-14 US News and World Report-America’s Top Doctors – Otolaryngology-Head & Neck Surgery
  • 2011 US News and World Report-America’s Top Doctors – Otolaryngology-Head & Neck Surgery
  • 2009 American Academy of Otolaryngology-Distinguished Service Award
  • 2006 Award for Excellence in Innovative Curricular Design and Program Development and Teaching
  • 2006 The Roger Boles, MD Award for Excellence in Clinical Faculty Teaching
  • 2001 George T. Nager MD Award for Excellence in Teaching, Department of Otolaryngology, Johns Hopkins University
  • 1999 Herbert Silverstein Award for Otologic Research - $10,000 - AAO-HNS Foundation
  • 1996 American Academy of Otolaryngology-Head & Neck Surgery Foundation, Inc. Foundation Grant Award
  • 1988 Dean's Summer Prize in Medical Student Research, UC San Francisco
  • 1987 UC Berkeley, graduation with Honors and Distinction in Scholarship
  • 1980 Eagle Scout, Boy Scouts of America
  • 1996 First Place Clinical Presentation, Bay Area Resident Research Association
  • 1992 UC San Francisco School of Medicine, Graduation with Honors

About Lawrence Lustig

Dr. Lawrence Lustig currently serves as the Howard W. Smith Professor and Chair of the Department of Otolaryngology—Head & Neck Surgery at Columbia University Medical Center and New York Presbyterian Hospital. He is a board certified Otolaryngologist with a sub-specialty certification in Neurotology. He has strong clinical and research interests. Clinically he treats the spectrum of disorders related to hearing, balance and the facial nerve. These range from simple ear infections, hearing loss and dizziness to complex tumors involving the ear and cranial base such as acoustic neuromas. He also performs surgery for a variety of types of hearing loss, including cochlear implants. Dr. Lustig takes great pride in providing top quality and compassionate clinical and surgical care to each and every patient he sees.

Lawrence Lustig, MD, - Chair, Department of Otolaryngology—Head & Neck Surgery

One of the nation's leading experts in hearing loss, Lawrence Lustig, MD, was appointed chair of the Department of Otolaryngology—Head and Neck Surgery at the Columbia University College of Physicians and Surgeons and otolaryngologist-in-chief at NewYork-Presbyterian Hospital/Columbia University Medical Center, effective July 1, 2014.

“We are very pleased to welcome Larry Lustig to our faculty,” said Lee Goldman, MD, dean of the faculties of health sciences and medicine, Columbia University Medical Center. “His experience and success leading major research and clinical programs will help us continue to grow our Department of Otolaryngology/Head and Neck Surgery’s basic, clinical, and translational research programs and our clinical enterprise, including even stronger collaboration with faculty across our departments.”

“Dr. Lustig’s extensive background in research and clinical care for hearing loss and related disorders will be pivotal to our continued provision of innovative, outstanding and patient-centered care, said Steven J. Corwin, MD, chief executive officer of NewYork-Presbyterian Hospital. “His expertise adds significantly to the depth and breadth of our ENT program, which addresses a range of health issues including hearing loss, benign and cancerous tumors, nasal and sinus disorders, voice and swallowing issues.”

Dr. Lustig treats the full spectrum of ear disorders in adults and children, as well as skull base disease. His specialties include skull base surgery, cochlear implants, the genetics of hearing loss, cochlear gene therapy, balance disorders, and hair cell physiology. He has led several NIH-funded research projects examining the underlying causes of hearing loss, including a recently completed a two-year $550,000 grant to explore cochlear gene therapy as a potential approach to treating children born with genetic forms of hearing loss.

This work stems from an initial study in which he and colleagues demonstrated that the inner hair cell glutamate-transporter VGLUT3 is integral to the development of hearing, while a mutation of the transporter causes early profound hearing loss. In follow-up studies, they demonstrated that virally mediated gene therapy can successfully restore the hearing phenotype in a mouse model of genetic deafness. Based on this work, they are currently exploring additional models of genetic deafness to see if these results can be duplicated. NIH has awarded a five-year grant to explore the use of virally mediated gene therapy to regenerate spiral (cochlear) ganglia—nerve cells that transport sound from the cochlea to the brain—to enable the sense of hearing. Dr. Lustig’s interdisciplinary research includes collaboration with an orthopedic surgery researcher at UCSF to study cochlear bone development. Using animal models and molecular techniques applied to bone growth and development, they are looking at how the material properties of bone enclosing the inner ear contribute to hearing.

They anticipate that their findings may help further understanding of how metabolic abnormalities cause certain types of hearing loss, including otosclerosis, Padget’s disease, and other conditions that cause defective bone development. Additional collaboration has included work with a pharmacologist at UCSF, where Dr. Lustig studied the mechanism of hearing loss caused by platinum-based chemotherapies. Dr. Lustig has published more than 125 articles in peer-reviewed journals, as well as book chapters. He co-edited a textbook, “Clinical Neurotology: Diagnosing and Managing Disorders of Hearing, Balance and the Facial Nerve.” In 2004, Dr. Lustig joined UCSF, where he has served as chief of the Division of Otology and Neurotology at both UCSF and San Francisco General Hospital, director of the Douglas Grant Cochlear Implant Center, clinical chief of the otolaryngology service on the Parnassus campus, and co-director of the Center for Balance and Falls.

Before joining UCSF, Dr. Lustig served on the faculty at Johns Hopkins University, where he was a member of the Johns Hopkins Listening Center and cochlear implant team. He also completed a fellowship in otology, neurotology, and skull base surgery at Hopkins. Dr. Lustig is a member of numerous professional organizations, including the American Otologic Society, the American Auditory Society, the Association for Research in Otolaryngology, the American Neurotology Society, and the North American Skull Base Society. He earned his bachelor’s degree in microbiology at the University of California, Berkeley, and his medical degree at UCSF, where he also completed a residency in otolaryngology/head and neck surgery.

Academic Titles

  • Howard W. Smith Professor of Otolaryngology—Head & Neck Surgery

Administrative Positions

  • Chair, Department of Otolaryngology—Head & Neck Surgery

Committee/Societies/Council Memberships

Dr. Lustig is actively involved in a number of professional organizations, including the American Academy of Otolaryngology-Head & Neck Surgery, the American Otologic Society, the American Neurotologic Society (President 2015-6), the Association for Research in Otolaryngology (President 2015-6), the Triological Society, the Society for Neuroscience, Society for University Otolaryngologists, the American Auditory Society, the New York Otologic Society, and is currently a Fellow of the New York Academy of Medicine as well as the American College of Surgeons.

Dr. Lustig has served on the editorial board of a number of academic journals, including serving as Associate Editor of Otology-Neurotology and the World Journal of Otolaryngology.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Insurance Accepted

For billing questions, please call (212) 305-1972.

Aetna

  • EPO
  • HMO
  • Indemnity
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Access (Exchange)
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • Medicare Managed Care
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

PHCS

  • PPO

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO
  • The Empire Plan (NYSHIP)

VNSNY CHOICE

  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
51 West 51st Street
New York, New York 10019
Phone:
(212) 326-8475
Fax:
(212) 305-8585
Primary
2
180 Fort Washington Avenue
New York, New York 10032
Phone:
(212) 326-8587
Fax:
(212) 305-3975

Research

Dr. Lustig's research focuses on understanding the molecular mechanisms of inner ear function and gene therapy approaches for hearing loss.  In his lab he has several animal models of inherited deafness for which they are using gene therapy to correct the hearing loss. The overall goal of these studies is to translate these research advances into human therapy that will one day cure genetic deafness.  These research studies have been supported by the National Institutes of Health and a number of private research foundations.    

Grants

A THREE PART,MULTICENTER, OPEN LABEL, SINGLE DOSE STUDY TO ASSESS THE SAFETY, TOLERABILITY & EFFICACY OF INTRALABYRINTHINE (IL) CGF166 IN PATIENTS WITH SEVERE HEARING LOSS (P&S Industry Clinical Trial)

Jan 15 2015 - Jan 15 2020

ASSESSMENT OF MIGRAINE (AND OTHER HEADACHE TYPES) IN OTOLARYNGOLOGY (Private)

Mar 14 2016 - Mar 13 2018

RESTORATION OF HEARING IN HE OTOFERLIN KO MOUSE USING DUAL AAV VECTOR (Private)

Jun 3 2016 - Mar 15 2017